http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
The Genomic Landscape and Clinical Relevance of A-to-I RNA Editing in Human Cancers
Han, L.,Diao, L.,Yu, S.,Xu, X.,Li, J.,Zhang, R.,Yang, Y.,Werner, Henrica M.J.,Eterovic, A.,Yuan, Y.,Li, J.,Nair, N.,Minelli, R.,Tsang, Y.,Cheung, Lydia W.T.,Jeong, K.,Roszik, J.,Ju, Z.,Woodman, Scott Cell Press 2015 CANCER CELL Vol. No.
Adenosine-to-inosine (A-to-I) RNA editing is a widespread post-transcriptional mechanism, but its genomic landscape and clinical relevance in cancer have not been investigated systematically. We characterized the global A-to-I RNA editing profiles of 6,236 patient samples of 17 cancer types from The Cancer Genome Atlas and revealed a striking diversity of altered RNA-editing patterns in tumors relative to normal tissues. We identified an appreciable number of clinically relevant editing events, many of which are in noncoding regions. We experimentally demonstrated the effects of several cross-tumor nonsynonymous RNA editing events on cell viability and provide the evidence that RNA editing could selectively affect drug sensitivity. These results highlight RNA editing as an exciting theme for investigating cancer mechanisms, biomarkers, and treatments.